bioRxiv Science⌕ Search

Biology subjects

Cuniasse, P.

Publications and source records attributed to Cuniasse, P..

3 recordsLinked to original sources

BRCA2 and RAD54B FxPP motifs Bind DMC1 Filaments through Persistent and Transient Interfaces

During meiosis, double-strand DNA breaks are programmed to initiate homologous recombination. The DMC1 recombinogenic filament is central to the repair of these breaks. However, the three-dimensional structures of the protein-protein interfaces regulating the assembly and activity of this filament have not been described yet. We and others previously reported that in BRCA2, a P-motif called PhePP binds to DMC1 in its oligomeric and filament states. Here we identified a similar P-motif in the DNA translocase RAD54B. We solved the cryo-electron microscopy (cryo-EM) structures of BRCA2 and RAD54B P-motif peptides bound to a ssDNA-DMC1 filament at 1.9-2.0 [A] resolution. While these peptides only share the sequence F-[IV]-P-P, they bind to the filament through larger 9-10 residue core sequences with superimposable structures. Both peptides bind to a hydrophobic and negatively charged site, named the P-site, on a single DMC1 protomer and stabilize the ssDNA-DMC1 filament. Mutagenesis experiments and molecular dynamics simulations identified additional transient interactions between positively charged residues of the peptides and negatively charged patches distributed on the DMC1 protomers. We propose that BRCA2 and RAD54B stably dock at the P-site of a single DMC1 protomer but also bridge two DMC1 protomers within the presynaptic filament via transient contacts with the adjacent protomer.

biochemistry↗

Restriction on Ku's Inward Translocation Caps Telomere Ends

Safeguarding chromosome ends against fusions via nonhomologous end joining (NHEJ) is essential for preserving genome integrity. Paradoxically, the conserved NHEJ core factor Ku binds telomere ends. How it is prevented from promoting NHEJ remains unclear, as does the mechanism that allows Ku to coexist with telomere-protective DNA binding proteins, e.g., Rap1 in Saccharomyces cerevisiae. Here, we reveal a direct role for Rap1 in the inhibition of Kus NHEJ function at telomeres. A single Rap1 molecule bound near a DNA end inhibits NHEJ in vivo without disrupting Ku presence. Consistent with this, Rap1 and Ku form a complex on short DNA duplexes in vitro. Cryo-EM and molecular modelling analysis of this complex shows that Rap1 obstructs Kus inward translocation on DNA - an essential step for NHEJ at broken ends. Nanopore sequencing of telomere fusions confirms the importance of this pathway in protecting native telomere ends. Collectively, our findings uncover a mechanism of telomere end protection mediated by restricting Kus inward translocation, a functional switch that prevents promiscuous NHEJ repair at telomeres.

molecular biology↗

Deep Mutational Engineering of broadly-neutralizing and picomolar affinity nanobodies to accommodate SARS-CoV-1 & 2 antigenic polymorphism

We report in this study the molecular engineering of nanobodies that bind with picomolar affinity to both SARS-CoV-1 and SARS-CoV-2 Receptor Binding Domains (RBD) and are highly neutralizing. We applied Deep Mutational Engineering to VHH72, a nanobody initially specific for SARS-CoV-1 RBD with little cross-reactivity to SARS-CoV-2 antigen. We first identified all the individual VHH substitutions that increase binding to SARS-CoV-2 RBD and then screened highly focused combinatorial libraries to isolate engineered nanobodies with improved properties. The corresponding VHH-Fc molecules show high affinities for SARS-CoV-2 antigens from various emerging variants and SARS-CoV-1, block the interaction between ACE2 and RBD and neutralize the virus with high efficiency. Its rare specificity across sarbecovirus relies on its peculiar epitope outside the immunodominant regions. The engineered nanobodies share a common motif of three amino acids, which contribute to the broad specificity of recognition. These nanobodies appears as promising therapeutic candidates to fight SARS-CoV-2 infection.

biochemistry↗